Lumida
/NEOG
⌘K
Neogen Corp

Neogen Corp

NEOG
$11.60USD-2.93%-0.35 today

MARKET CAP

2.5B

P/E (TTM)

64.7x

FWD P/E

DAY RANGE

$12 – $12

52W RANGE

$5
$13

AI Summary

Stalk
Buy NowMedium

NEOG is in a Stage 2 Advance with structural alignment above its breakout pivot, supported by rising EMAs and a confirmed momentum breakout. The medium-term bias remains bullish, and short-term conditions favor immediate execution. Under a Speculative approach, we initiate a continuation participation, buying into current consolidation above the 9/20 EMA support zone near ~$11.75–$12.00.

  • Q4 2026 revenue $225.3M, core growth 4.3%, food safety +5.8%.
  • Adjusted EBITDA margin improved to 20.2%; free cash flow exceeded $26M.
  • Animal safety core revenue declined ~8.7% due to supplier issues.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$468.5M$527.2M$822.4M$924.2M$894.7M
YoY %+12.0%+12.5%+56.0%+12.4%-3.2%
P / Sales10.4x5.4x4.0x3.1x1.4x
EV / Sales10.4x5.5x5.5x4.4x2.8x
Gross Profit, Adj.$215.1M$243.0M$406.0M$463.9M$421.4M
YoY %+9.6%+13.0%+67.1%+14.3%-9.2%
Margin %45.9%46.1%49.4%50.2%47.1%
EV / Gross Profit22.7x12.0x11.2x8.8x5.9x
EBITDA, Adj.$95.2M$82.3M$125.4M$176.5M$117.8M
YoY %+10.8%-13.5%+52.4%+40.7%-33.3%
Margin %20.3%15.6%15.2%19.1%13.2%
EV / EBITDA51.4x35.5x36.4x23.1x21.0x
EBIT$74.2M$58.6M$37.5M$58.7M$-1.1B
YoY %+9.8%-21.0%-36.0%+56.4%-1908.6%
Margin %15.8%11.1%4.6%6.3%-118.6%
EV / EBIT65.9x49.8x121.6x69.6x-2.3x
Net Income$60.9M$48.3M$-22.9M$-9.4M$-1.1B
YoY %+2.4%-20.7%-147.3%+58.8%-11491.6%
Net Margin13.0%9.2%-2.8%-1.0%-122.1%
EPS (GAAP)$0.57$0.45-$0.12-$0.04-$5.03
YoY %+1.8%-21.1%-126.7%+66.7%-12475.0%